Considering our data and evidence from mouse models (23–25), the induction of CXCL12 in skeletal muscle from individuals with type 2 diabetes is therefore likely a beneficial response, promoting local muscle stem cell recruitment and activation, leading to skeletal muscle remodeling. This evidence concerns the gene CXCL12 and type 2 diabetes mellitus.